Chemical modification motifs for miRNA inhibitors and mimetics

Details for Australian Patent Application No. 2010258875 (hide)

Owner Miragen Therapeutics

Inventors Yamada, Christina; Marshall, William S.

Agent Pizzeys

Pub. Number AU-A-2010258875

PCT Pub. Number WO2010/144485

Priority 61/185,033 08.06.09 US

Filing date 8 June 2010

Wipo publication date 16 December 2010

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/144485 Priority application(s): WO2010/144485

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258888-Treatment of portal hypertension and restoration of liver function using Lornithine phenylacetate

2010258872-Systems and methods for the identification of compounds in medical fluids using admittance spectroscopy